Black Diamond Therapeutics Inc (BDTX)

Dec 09, 2025

A strong week for data readouts: Clinical Report - BioCentury

Dec 09, 2025

Dec 08, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 08, 2025

Dec 05, 2025

Can Black Diamond Therapeutics (BDTX) Turn Silevertinib’s Dual-Cancer Ambition Into a Cohesive Strategy? - Yahoo Finance

Dec 05, 2025

Dec 05, 2025

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX) - sharewise.com

Dec 05, 2025

Dec 05, 2025

Can Black Diamond Therapeutics Inc. stock continue upward trendGap Down & Long-Term Investment Growth Plans - Newser

Dec 05, 2025

Dec 05, 2025

Will Black Diamond Therapeutics Inc. stock attract more institutional investorsInsider Selling & Technical Pattern Based Buy Signals - Newser

Dec 05, 2025

Dec 04, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Lowered by Guggenheim - MarketBeat

Dec 04, 2025

Dec 04, 2025

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8 - Investing.com Australia

Dec 04, 2025

Dec 04, 2025

Analyst Downgrades BDTX to Neutral from Buy | BDTX Stock News - GuruFocus

Dec 04, 2025

Dec 04, 2025

This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga

Dec 04, 2025

Dec 04, 2025

How Black Diamond Therapeutics Inc. stock reacts to oil pricesBond Market & Consistent Profit Trade Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data - Sahm

Dec 03, 2025

Dec 03, 2025

Are Smart Investors Making the Right Decision? Black Diamond Therapeutics Inc (BDTX) - Setenews

Dec 03, 2025

Dec 03, 2025

US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Benzinga

Dec 03, 2025

Dec 03, 2025

Black Diamond Therapeutics announces preliminary Phase 2 data for Silevertinib in 1L NSCLC - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Black Diamond Therapeutics (BDTX) Reveals Promising Phase 2 Tria - GuruFocus

Dec 03, 2025

Dec 03, 2025

Black Diamond Therapeutics Announces Preliminary Phase 2 - GlobeNewswire

Dec 03, 2025

Dec 03, 2025

Black Diamond to present Phase 2 silevertinib trial results By Investing.com - Investing.com Canada

Dec 03, 2025

Dec 02, 2025

Black Diamond to present Phase 2 silevertinib trial results - Investing.com India

Dec 02, 2025

Dec 02, 2025

Black Diamond Therapeutics to Host Webcast on Phase 2 Clinical Trial Results of Silevertinib on December 3, 2025 - Quiver Quantitative

Dec 02, 2025

Dec 02, 2025

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update - The Manila Times

Dec 02, 2025

Dec 02, 2025

Black Diamond Therapeutics to Host Webcast Presentation - GlobeNewswire

Dec 02, 2025

Dec 02, 2025

Black Diamond Therapeutics, Inc. (BDTX) -9.9% in Intraday Trading: Decline Amid Routine Activity - Stocks Telegraph

Dec 02, 2025

Dec 02, 2025

Black Diamond Therapeutics (Nasdaq: BDTX) to present silevertinib Phase 2 trial results in Dec. 3 webcast - Stock Titan

Dec 02, 2025

Nov 29, 2025

Is Black Diamond Therapeutics Inc a good long term investmentCandlestick Trading Patterns & Learn to Trade with Real-Time Feedback - earlytimes.in

Nov 29, 2025

Nov 26, 2025

Adversity is less terrifying than hope: Black Diamond Therapeutics Inc (BDTX) - Setenews

Nov 26, 2025

Nov 26, 2025

Aug Retail: Why Black Diamond Therapeutics Inc. stock could benefit from AI revolutionTrade Volume Report & Expert Curated Trade Ideas - moha.gov.vn

Nov 26, 2025

Nov 21, 2025

Black Diamond Therapeutics Inc. (BDTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 21, 2025

What insider trading reveals about Black Diamond Therapeutics Inc. stockQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Black Diamond Therapeutics: Underappreciated Despite An Upcoming Key Readout (NASDAQ:BDTX) - Seeking Alpha

Nov 20, 2025

Nov 20, 2025

Will Black Diamond Therapeutics Inc. stock pay special dividends2025 Momentum Check & Reliable Intraday Trade Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Rating Increased to Strong-Buy at Piper Sandler - MarketBeat

Nov 20, 2025

Nov 20, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Piper Sandler - Defense World

Nov 20, 2025

Nov 19, 2025

Can Black Diamond Therapeutics Inc. stock hit record highs againJuly 2025 Review & Comprehensive Market Scan Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Will Black Diamond Therapeutics Inc. stock maintain momentum in 2025July 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Volume spikes in Black Diamond Therapeutics Inc. stock – what they meanQuarterly Growth Report & Expert Curated Trade Setups - newser.com

Nov 19, 2025

Nov 19, 2025

Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX) - MarketBeat

Nov 19, 2025

Nov 18, 2025

How geopolitical tensions affect Black Diamond Therapeutics Inc. stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com

Nov 18, 2025